Color Doppler and hormone replacement therapy: the role of thromboxane and plasma viscosity.
The aim of the study was to evaluate the plasma thromboxane and plasma viscosity in relation with Doppler flow parameters in postmenopausal patients treated with hormone replacement therapy. Thirty-two postmenopausal (follicle-stimulating hormone > 40 IU/l and estradiol < 100 pmol/l) women (mean age +/- SD, 54.7 +/- 2.9 years) participated in the study and were submitted to continuous estradiol transdermal supplementation and 12-day courses of medroxyprogesterone acetate every second month. Doppler resistances at the level of the uterine and internal carotid arteries, thromboxane plasma levels and plasma viscosity were analyzed in basal condition and after 1, 3 and 6 months. During hormone supplementation, the pulsatility index significantly decreased at the level of the analyzed arteries. Similarly, plasma thromboxane levels and plasma viscosity were significantly reduced. Significant correlations were found between thromboxane plasma concentrations, plasma viscosity and uterine artery resistances. Thus hormone replacement therapy seems to be responsible for both direct and indirect modifications at the level of the vessel wall physiology.
Battaglia
C
C
Department of Obstetrics and Gynecology, University of Modena, Italy.
Salvatori
M
M
Gallinelli
A
A
Artini
P G
PG
Genazzani
A R
AR
Volpe
A
A
D001809:Blood Viscosity / Q000187:drug effects / Q000502:physiology*; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology*; D008875:Middle Aged; D017698:Postmenopause; D045167:Progesterone Congeners / Q000494:pharmacology*; D011673:Pulsatile Flow / Q000187:drug effects; D013931:Thromboxanes / Q000097:blood*; D018615:Ultrasonography, Doppler, Color
D045167:Progesterone Congeners; D013931:Thromboxanes; D004958:Estradiol; D017258:Medroxyprogesterone Acetate